Chad Robins

Chad Robins

Chief Executive Officer and ChairmanatAdaptive Biotechnologies· In proxies 2021–2025

Pay in FY2023+1% from the year before · Adaptive Biotechnologies stock -35.9% the same year

Chad Robins was paid $8.9M in FY2023 (Dec), up 1%. Adaptive Biotechnologies stock fell 35.9% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each Adaptive Biotechnologies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Adaptive BiotechnologiesPublic company · 5 yr
    • Chief Executive Officer and Chairman2021 – Present · 5 yrStock in role -55%
  2. CM Life Sciences III, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Coalition for 21st Century MedicinePublic company
    • Director? – PresentNo stock prices for these years
  4. Headlight, Washington Roundtable, AltPepPublic company
    • Director? – PresentNo stock prices for these years
  5. Life Science WashingtonPublic company
    • Director? – PresentNo stock prices for these years
  6. ARYA Sciences Acquisition Corp IIPublic company · Less than 1 yr
    • Director2020 – 2020 · Less than 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?